Open original FDA record ↗Recall record
- FDA identifier
- Z-2719-2024
- Company in FDA record
- Neurovision Medical Products Inc
- FDA classification date
- Aug 23, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
mislabeling; EMG RLN monitoring kit labeling contains the incorrect tube size.
Source facts
- Action
- On July 11, 2024, Neurovision Medical Products issued a "Urgent Medical Device Recall Notice" to affected consignees via E-Mail. Neurovision ask consignees to take the following actions: immediately take the following actions: 1. Review your inventory for the lot mentioned above REF code and lot. 2. Quarantine product subject to this notice. 3. Cease distribution and use of any product from the affected lots. 4. Pass this notice on to all who need to be aware within your organization or to any organization where the potentially affected product with the specified lot number has been transferred or distributed. 5. Complete and return the enclosed response form as soon as possible: a. Email: customer service @neurovisionmedical.com b. Fax: (877) 330-1727 6. NMP Customer Service will respond with a return authorization (RMA) number and return shipping label for any remaining stock. 7. If you have distributed this product to another location or entity, notify them of this product recall (include a copy of this notice), and contact NMP Customer Service for return authorization (RMA).
- Initiated
- 2024-07-01
- Root cause
- Process control
- Distribution
- US Nationwide distribution.
- Recall number
- Z-2719-2024
- Recall status
- Open, Classified
- CDRH record ID
- 209129
- FDA classified
- 2024-08-23
- Recall event number
- 94931